{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:35:05Z","timestamp":1784561705386,"version":"3.55.0"},"reference-count":97,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF protein superfamily, represents a multifaceted cytokine with unique biological features including both proapoptotic and pro-survival effects in different cell types depending on receptor interactions and local stimuli. Beyond its extensively studied anti-tumor and immunomodulatory properties, a growing body of experimental and clinical evidence over the past two decades suggests a protective role of TRAIL in the development of type 1 (T1DM) and type 2 (T2DM) diabetes mellitus. This evidence can be briefly summarized by the following observations: (i) acceleration and exacerbation of T1DM and T2DM by TRAIL blockade or genetic deficiency in animal models, (ii) prevention and amelioration of T1DM and T2DM with recombinant TRAIL treatment or systemic TRAIL gene delivery in animal models, (iii) significantly reduced circulating soluble TRAIL levels in patients with T1DM and T2DM both at disease onset and in more advanced stages of diabetes-related complications such as cardiovascular disease and diabetic nephropathy, (iv) increase of serum TRAIL levels in diabetic patients after initiation of antidiabetic treatment and metabolic improvement. To explore the underlying mechanisms and provide mechanistic links between TRAIL and diabetes, a number of animal and in vitro studies have reported direct effects of TRAIL on several tissues involved in diabetes pathophysiology such as pancreatic islets, skeletal muscle, adipose tissue, liver, kidney, and immune and vascular cells. Residual controversy remains regarding the effects of TRAIL on adipose tissue homeostasis. Although the existing evidence is encouraging and paves the way for investigating TRAIL-related interventions in diabetic patients with cardiometabolic abnormalities, caution is warranted in the extrapolation of animal and in vitro data to the clinical setting, and further research in humans is imperative in order to uncover all aspects of the TRAIL-diabetes relationship and delineate its therapeutic implications in metabolic disease.<\/jats:p>","DOI":"10.3390\/ijms23063225","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:30:14Z","timestamp":1647811814000},"page":"3225","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-727X","authenticated-orcid":false,"given":"Chrysi","family":"Koliaki","sequence":"first","affiliation":[{"name":"First Propaedeutic Department of Internal Medicine and Diabetes Center, Medical Faculty, Laiko General Hospital, National Kapodistrian University of Athens, 17 Agiou Thoma Street, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Katsilambros","sequence":"additional","affiliation":[{"name":"First Propaedeutic Department of Internal Medicine and Diabetes Center, Medical Faculty, Laiko General Hospital, National Kapodistrian University of Athens, 17 Agiou Thoma Street, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0968-0004(01)01995-8","article-title":"The Molecular Architecture of the TNF Superfamily","volume":"27","author":"Bodmer","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"ref_2","first-page":"1356","article-title":"Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice","volume":"168","author":"Cretney","year":"2002","journal-title":"J. Immunol. Baltim. Md."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20011171","article-title":"Critical Role for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Immune Surveillance against Tumor Development","volume":"195","author":"Takeda","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rossin, A., Miloro, G., and Hueber, A.O. (2019). TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity. Cancers, 11.","DOI":"10.3390\/cancers11050639"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and Characterization of a New Member of the TNF Family That Induces Apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI34359","article-title":"To Kill a Tumor Cell: The Potential of Proapoptotic Receptor Agonists","volume":"118","author":"Ashkenazi","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00018-004-4197-6","article-title":"TRAIL Promotes the Survival, Migration and Proliferation of Vascular Smooth Muscle Cells","volume":"61","author":"Secchiero","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.0000062702.60708.C4","article-title":"TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways","volume":"107","author":"Secchiero","year":"2003","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.4161\/auto.22145","article-title":"Attenuation of TNFSF10\/TRAIL-Induced Apoptosis by an Autophagic Survival Pathway Involving TRAF2- And RIPK1\/RIP1-Mediated MAPK8\/JNK Activation","volume":"8","author":"He","year":"2012","journal-title":"Autophagy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1471-4159.2003.01805.x","article-title":"Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand Sequentially Activates pro-Survival and pro-Apoptotic Pathways in SK-N-MC Neuronal Cells","volume":"86","author":"Milani","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1158\/0008-5472.CAN-06-3896","article-title":"Lipid Rafts and Nonrafts Mediate Tumor Necrosis Factor Related Apoptosis-Inducing Ligand Induced Apoptotic and Nonapoptotic Signals in Non Small Cell Lung Carcinoma Cells","volume":"67","author":"Song","year":"2007","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.2174\/138161212803530925","article-title":"Potential Role of TRAIL in the Management of Autoimmune Diabetes Mellitus","volume":"18","author":"Bernardi","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tem.2013.07.001","article-title":"On the TRAIL of Obesity and Diabetes","volume":"24","author":"Harith","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"680749","DOI":"10.1155\/2015\/680749","article-title":"TRAIL Modulates the Immune System and Protects against the Development of Diabetes","volume":"2015","author":"Bossi","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.2337\/diabetes.52.9.2274","article-title":"Critical Roles of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Type 1 Diabetes","volume":"52","author":"Zheng","year":"2003","journal-title":"Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41598-017-01721-4","article-title":"Non-Alcoholic Fatty Liver Disease, Vascular Inflammation and Insulin Resistance Are Exacerbated by TRAIL Deletion in Mice","volume":"7","author":"Cartland","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00125-011-2308-0","article-title":"TNF-Related Apoptosis-Inducing Ligand (TRAIL) Protects against Diabetes and Atherosclerosis in Apoe\/Mice","volume":"54","author":"Chan","year":"2011","journal-title":"Diabetologia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2337\/db09-1771","article-title":"Treatment with Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes","volume":"59","author":"Zauli","year":"2010","journal-title":"Diabetes"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/CS20120176","article-title":"TNF-Related Apoptosis-Inducing Ligand Significantly Attenuates Metabolic Abnormalities in High-Fat-Fed Mice Reducing Adiposity and Systemic Inflammation","volume":"123","author":"Bernardi","year":"2012","journal-title":"Clin. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/CS20171221","article-title":"TRAIL Reduces Impaired Glucose Tolerance and NAFLD in the High-Fat Diet Fed Mouse","volume":"132","author":"Bernardi","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1210\/en.2009-0478","article-title":"Systemic Delivery of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Elevates Levels of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) and Prevents Type 1 Diabetes in Nonobese Diabetic Mice","volume":"151","author":"Kang","year":"2010","journal-title":"Endocrinology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/hum.2009.039","article-title":"Adenovirus-Mediated TRAIL Gene (Ad5hTRAIL) Delivery into Pancreatic Islets Prolongs Normoglycemia in Streptozotocin-Induced Diabetic Rats","volume":"20","author":"Dirice","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00592-013-0507-5","article-title":"The Levels of Circulating TRAIL at the Onset of Type 1 Diabetes Are Markedly Decreased in Patients with Ketoacidosis and with the Highest Insulin Requirement","volume":"51","author":"Tornese","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2012.02.028","article-title":"Circulating Soluble Tumor Necrosis Factor Related Apoptosis Inducing-Ligand (TRAIL) Is Decreased in Type-2 Newly Diagnosed, Non-Drug Using Diabetic Patients","volume":"96","author":"Bisgin","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Secchiero, P., Corallini, F., Ceconi, C., Parrinello, G., Volpato, S., Ferrari, R., and Zauli, G. (2009). Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004442"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jacc.2004.12.065","article-title":"The Involvement of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Atherosclerosis","volume":"45","author":"Michowitz","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.12659\/MSM.889514","article-title":"Association of Circulating STRAIL and High-Sensitivity CRP with Type 2 Diabetic Nephropathy and Foot Ulcers","volume":"19","author":"Arik","year":"2013","journal-title":"Med. Sci. Monit."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1470320318785744","DOI":"10.1177\/1470320318785744","article-title":"Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand Expression in Patients with Diabetic Nephropathy","volume":"19","author":"Chang","year":"2018","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1080\/09273948.2017.1343855","article-title":"Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy","volume":"26","author":"Ahmad","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/cen.12312","article-title":"Circulating Level of TRAIL Concentration Is Positively Associated with Endothelial Function and Increased by Diabetic Therapy in the Newly Diagnosed Type 2 Diabetic Patients","volume":"80","author":"Xiang","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/diabetes.52.8.1967","article-title":"Blockade of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Exacerbates Type 1 Diabetes in NOD Mice","volume":"52","author":"Mi","year":"2003","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/JME-20-0037","article-title":"TRAIL Induces Proliferation in Rodent Pancreatic Beta Cells via AKT Activation","volume":"66","author":"Kahraman","year":"2021","journal-title":"J. Mol. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41419-021-04383-3","article-title":"TRAIL\/DR5 Pathway Promotes AKT Phosphorylation, Skeletal Muscle Differentiation, and Glucose Uptake","volume":"12","author":"Toffoli","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1042\/CS20201004","article-title":"TRAIL Treatment Prevents Renal Morphological Changes and TGF-\u03b2-Induced Mesenchymal Transition Associated with Diabetic Nephropathy","volume":"134","author":"Toffoli","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1752854","DOI":"10.1155\/2016\/1752854","article-title":"Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL","volume":"277","author":"Pan","year":"1997","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The Receptor for the Cytotoxic Ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng1097-141","article-title":"KILLER\/DR5 Is a DNA Damage-Inducible P53-Regulated Death Receptor Gene","volume":"17","author":"Wu","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.186.7.1165","article-title":"Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family","volume":"186","author":"Smolak","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00018-008-8536-x","article-title":"Role of Full-Length Osteoprotegerin in Tumor Cell Biology","volume":"66","author":"Zauli","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1074-7613(00)80399-4","article-title":"The Novel Receptor TRAIL-R4 Induces NF-\u039aB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain","volume":"7","author":"Dougall","year":"1997","journal-title":"Immunity"},{"key":"ref_43","first-page":"2770","article-title":"Molecular Cloning and Functional Analysis of the Mouse Homologue of the KILLER\/DR5 Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Death Receptor","volume":"59","author":"Wu","year":"1999","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","article-title":"Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)","volume":"190","author":"Fanger","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/cimm.2001.1896","article-title":"Involvement of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in NK Cell-Mediated and IFN-Gamma-Dependent Suppression of Subcutaneous Tumor Growth","volume":"214","author":"Takeda","year":"2001","journal-title":"Cell. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X","article-title":"Surface Expression of TRAIL\/Apo-2 Ligand in Activated Mouse T and B Cells","volume":"28","author":"Mariani","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","article-title":"Type I Interferons (IFNs) Regulate Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of Type I IFNs","volume":"189","author":"Kayagaki","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biocel.2016.09.019","article-title":"Redox Signaling and Oxidative Stress: Cross Talk with TNF-Related Apoptosis Inducing Ligand Activity","volume":"81","author":"Voltan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/cdd.2012.90","article-title":"TRAIL Induces Necroptosis Involving RIPK1\/RIPK3-Dependent PARP-1 Activation","volume":"19","author":"Arshad","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.devcel.2016.04.018","article-title":"The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis","volume":"37","author":"Goodall","year":"2016","journal-title":"Dev. Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/cdd.2013.28","article-title":"Non-Canonical Kinase Signaling by the Death Ligand TRAIL in Cancer Cells: Discord in the Death Receptor Family","volume":"20","author":"Azijli","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.bcp.2007.10.020","article-title":"Expression, Regulation and Function of Trail in Atherosclerosis","volume":"75","author":"Kavurma","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2010.02.024","article-title":"Metalloproteinase 2 Cleaves in Vitro Recombinant TRAIL: Potential Implications for the Decreased Serum Levels of TRAIL after Acute Myocardial Infarction","volume":"211","author":"Secchiero","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00592-015-0731-2","article-title":"Serum TRAIL Levels Increase Shortly after Insulin Therapy and Metabolic Stabilization in Children with Type 1 Diabetes Mellitus","volume":"52","author":"Tornese","year":"2015","journal-title":"Acta Diabetol."},{"key":"ref_55","first-page":"21","article-title":"Analysis of 22 Immunomodulatory Substances for Efficacy in Low-Dose Streptozotocin-Induced Diabetes","volume":"6","author":"Kolb","year":"1987","journal-title":"Diabetes Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.mpa.0000148515.77497.4b","article-title":"Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and CD56 Expression in Patients with Type 1 Diabetes Mellitus","volume":"30","author":"Cheung","year":"2005","journal-title":"Pancreas"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7754\/Clin.Lab.2018.171130","article-title":"Fas and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Are Closely Linked to the Levels of Glycated and Fetal Hemoglobin in Patients with Diabetes Mellitus","volume":"64","author":"Choi","year":"2018","journal-title":"Clin. Lab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/cddis.2012.212","article-title":"TRAIL (TNF-Related Apoptosis-Inducing Ligand) Regulates Adipocyte Metabolism by Caspase-Mediated Cleavage of PPARgamma","volume":"4","author":"Keuper","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1038\/s41598-017-05932-7","article-title":"Trail (TNF-Related Apoptosis-Inducing Ligand) Induces an Inflammatory Response in Human Adipocytes","volume":"7","author":"Zoller","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/db19-1231","article-title":"A Trail-Tl1a Paracrine Network Involving Adipocytes, Macrophages, and Lymphocytes Induces Adipose Tissue Dysfunction Downstream of E2f1 in Human Obesity","volume":"69","author":"Maixner","year":"2020","journal-title":"Diabetes"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/cddis.2016.286","article-title":"TRAIL (TNF-Related Apoptosis-Inducing Ligand) Inhibits Human Adipocyte Differentiation via Caspase-Mediated Downregulation of Adipogenic Transcription Factors","volume":"7","author":"Zoller","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jhep.2014.11.033","article-title":"TRAIL Receptor Deletion in Mice Suppresses the Inflammation of Nutrient Excess","volume":"62","author":"Idrissova","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1096\/fj.14-267278","article-title":"TNF-Related Apoptosis-Inducing Ligand Promotes Human Preadipocyte Proliferation via ERK1\/2 Activation","volume":"29","author":"Funcke","year":"2015","journal-title":"FASEB J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI45887","article-title":"Adipose Tissue Remodeling and Obesity","volume":"121","author":"Sun","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.metabol.2010.10.001","article-title":"Similar to Adiponectin, Serum Levels of Osteoprotegerin Are Associated with Obesity in Healthy Subjects","volume":"60","author":"Ashley","year":"2011","journal-title":"Metab. Clin. Exp."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Brombo, G., Volpato, S., Secchiero, P., Passaro, A., Bosi, C., Zuliani, G., and Zauli, G. (2013). Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058225"},{"key":"ref_67","first-page":"400","article-title":"Associations of Serum TRAIL Concentrations, Anthropometric Variables, and Serum Lipid Parameters in Healthy Adults","volume":"34","author":"Choi","year":"2004","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.diabres.2010.11.034","article-title":"Association of Serum TRAIL Levels with Atherosclerosis in Patients with Type 2 Diabetes Mellitus","volume":"91","author":"Kawano","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.168.10.4881","article-title":"Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)Antigen-Specific T Cells","volume":"168","author":"Waiczies","year":"2002","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.191.7.1095","article-title":"Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression","volume":"191","author":"Song","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1073\/pnas.091100398","article-title":"Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in T Cell Development: Sensitivity of Human Thymocytes","volume":"98","author":"Simon","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni894","article-title":"Defective Thymocyte Apoptosis and Accelerated Autoimmune Diseases in TRAIL\/Mice","volume":"4","author":"Zheng","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/immunohorizons.2000098","article-title":"Regulatory T Cell\u2013Derived TRAIL Is Not Required for Peripheral Tolerance","volume":"5","author":"Dadey","year":"2021","journal-title":"ImmunoHorizons"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.4049\/jimmunol.0902797","article-title":"Dual Effects of TRAIL in Suppression of Autoimmunity: The Inhibition of Th1 Cells and the Promotion of Regulatory T Cells","volume":"185","author":"Ikeda","year":"2010","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/jcb.21677","article-title":"Molecular Mechanisms of Death Ligand-Mediated Immune Modulation: A Gene Therapy Model to Prolong Islet Survival in Type 1 Diabetes","volume":"104","author":"Sanlioglu","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2567.2009.03058.x","article-title":"Following TRAIL\u2019s Path in the Immune System","volume":"127","author":"Falschlehner","year":"2009","journal-title":"Immunology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/JOE-15-0533","article-title":"Insulin Resistance and Sarcopenia: Mechanistic Links between Common Co-Morbidities","volume":"229","author":"Cleasby","year":"2016","journal-title":"J. Endocrinol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6529728","DOI":"10.1155\/2016\/6529728","article-title":"Dyslipidemia and Diabetes Increase the OPG\/TRAIL Ratio in the Cardiovascular System","volume":"2016","author":"Toffoli","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/01.RES.0000067928.83455.9C","article-title":"Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sequentially Upregulates Nitric Oxide and Prostanoid Production in Primary Human Endothelial Cells","volume":"92","author":"Zauli","year":"2003","journal-title":"Circ. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.isci.2018.12.037","article-title":"TRAIL-Expressing Monocyte\/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis","volume":"12","author":"Cartland","year":"2019","journal-title":"iScience"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.106.643841","article-title":"Systemic Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery Shows Antiatherosclerotic Activity in Apolipoprotein E-Null Diabetic Mice","volume":"114","author":"Secchiero","year":"2006","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Di Bartolo, B.A., Cartland, S.P., Harith, H.H., Bobryshev, Y.V., Schoppet, M., and Kavurma, M.M. (2013). TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL. PLoS ONE, 8.","DOI":"10.1371\/annotation\/9732ca63-7532-4b92-8d6e-65c0863f25aa"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10637-010-9627-8","article-title":"TRAIL Shows Potential Cardioprotective Activity","volume":"30","author":"Toffoli","year":"2012","journal-title":"Investig. New Drugs"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/heartjnl-2011-300339","article-title":"Association of Soluble Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand Levels with Coronary Plaque Burden and Composition","volume":"98","author":"Deftereos","year":"2012","journal-title":"Heart"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.atherosclerosis.2010.11.004","article-title":"Association of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand with Total and Cardiovascular Mortality in Older Adults","volume":"215","author":"Volpato","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ebiom.2017.11.023","article-title":"Elevated Markers of Death Receptor-Activated Apoptosis Are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease","volume":"26","author":"Mattisson","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2015.03.028","article-title":"Low Serum TNF-Related Apoptosis-Inducing Ligand (TRAIL) Levels Are Associated with Acute Ischemic Stroke Severity","volume":"240","author":"Kang","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14489","DOI":"10.1097\/MD.0000000000014489","article-title":"Inverse Regulation of Serum Osteoprotegerin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Patients with Leg Lesional Vascular Calcification: An Observational Study","volume":"98","author":"Moon","year":"2019","journal-title":"Medicine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e002527","DOI":"10.1161\/JAHA.115.002527","article-title":"Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms","volume":"4","author":"Cartland","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1042\/CS20181116","article-title":"TRAIL, OPG, and TWEAK in Kidney Disease: Biomarkers or Therapeutic Targets?","volume":"113","author":"Bernardi","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1681\/ASN.2007050581","article-title":"The Death Ligand TRAIL in Diabetic Nephropathy","volume":"19","author":"Lorz","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Cartland, S.P., Erlich, J.H., and Kavurma, M.M. (2014). TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE\/Mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092952"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e31828aa6fb","article-title":"Ocular Disease, Knowledge and Technology Applications in Patients with Diabetes","volume":"345","author":"Threatt","year":"2013","journal-title":"Am. J. Med. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2353\/ajpath.2009.090099","article-title":"TRAIL-Deficient Mice Exhibit Delayed Regression of Retinal Neovascularization","volume":"175","author":"Hubert","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1464-5491.2010.03202.x","article-title":"Decreased Levels of Soluble TNF-Related Apoptosis-Inducing Ligand (TRAIL) in the Conjunctival Sac Fluid of Patients with Diabetes Affected by Proliferative Retinopathy","volume":"28","author":"Secchiero","year":"2011","journal-title":"Diabet. Med. J. Br. Diabet. Assoc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1038\/srep04114","article-title":"Does DcR1 (TNF-Related Apoptosis-Inducing-Ligand Receptor 3) Have Any Role in Human AMD Pathogenesis?","volume":"4","author":"Anand","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.120.11.1435","article-title":"The Role of Apoptosis in Age-Related Macular Degeneration","volume":"120","author":"Dunaief","year":"2002","journal-title":"Arch. Ophthalmol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3225\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:58Z","timestamp":1760135878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":97,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijms23063225"],"URL":"https:\/\/doi.org\/10.3390\/ijms23063225","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]}}}